495 related articles for article (PubMed ID: 26880384)
1. The role of neoadjuvant therapy in pancreatic cancer: a review.
Russo S; Ammori J; Eads J; Dorth J
Future Oncol; 2016 Mar; 12(5):669-85. PubMed ID: 26880384
[TBL] [Abstract][Full Text] [Related]
2. Trends in Neoadjuvant Approaches in Pancreatic Cancer.
Du L; Wang-Gillam A
J Natl Compr Canc Netw; 2017 Aug; 15(8):1070-1077. PubMed ID: 28784867
[TBL] [Abstract][Full Text] [Related]
3. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer.
Barnes CA; Aldakkak M; Christians KK; Clarke CN; Dua K; George B; Ritch PS; Kamgar M; Hall WA; Kulkarni N; Erickson BA; Evans DB; Tsai S
Surgery; 2020 Sep; 168(3):440-447. PubMed ID: 32641278
[TBL] [Abstract][Full Text] [Related]
4. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
5. Current status of adjuvant therapy for pancreatic cancer.
Katz MH; Fleming JB; Lee JE; Pisters PW
Oncologist; 2010; 15(11):1205-13. PubMed ID: 21045189
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for pancreas cancer: Global perspective and optimal care pathways in low to middle-income countries.
Rajappa SJ; Pinninti R; Are C
J Surg Oncol; 2021 May; 123(6):1441-1448. PubMed ID: 33831251
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.
Barnes CA; Chavez MI; Tsai S; Aldakkak M; George B; Ritch PS; Dua K; Clarke CN; Tolat P; Hagen C; Hall WA; Erickson BA; Evans DB; Christians KK
Surgery; 2019 Sep; 166(3):277-285. PubMed ID: 31272811
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant and neoadjuvant therapy for resectable pancreatic adenocarcinoma.
Sohal DPS
Chin Clin Oncol; 2017 Jun; 6(3):26. PubMed ID: 28705003
[TBL] [Abstract][Full Text] [Related]
10. Current standards and new innovative approaches for treatment of pancreatic cancer.
Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
[TBL] [Abstract][Full Text] [Related]
11. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
12. Status of neoadjuvant therapy for resectable pancreatic cancer.
Hoffman JP
Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
14. Borderline Resectable and Locally Advanced Pancreatic Cancers: A Review of Definitions, Diagnostics, Strategies for Treatment, and Future Directions.
Khachfe HH; Habib JR; Nassour I; Al Harthi S; Jamali FR
Pancreas; 2021 Oct; 50(9):1243-1249. PubMed ID: 34860806
[TBL] [Abstract][Full Text] [Related]
15. Randomized Clinical Trials in Pancreatic Cancer.
Goel N; Reddy SS
Surg Oncol Clin N Am; 2017 Oct; 26(4):767-790. PubMed ID: 28923230
[TBL] [Abstract][Full Text] [Related]
16. Approach to patients with pancreatic cancer without detectable metastases.
Heestand GM; Murphy JD; Lowy AM
J Clin Oncol; 2015 Jun; 33(16):1770-8. PubMed ID: 25918279
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation.
Hoffe S; Rao N; Shridhar R
Semin Radiat Oncol; 2014 Apr; 24(2):113-25. PubMed ID: 24635868
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer.
Patel M; Hoffe S; Malafa M; Hodul P; Klapman J; Centeno B; Kim J; Helm J; Valone T; Springett G
J Surg Oncol; 2011 Aug; 104(2):155-61. PubMed ID: 21520097
[TBL] [Abstract][Full Text] [Related]
19. Localized Pancreatic Cancer: Multidisciplinary Management.
Coveler AL; Herman JM; Simeone DM; Chiorean EG
Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
